Adjuvant pembrolizumab beneficial in renal cell carcinoma

(HealthDay) —For patients with renal cell renal cell carcinoma at high risk of recurrence after nephrectomy, adjuvant treatment with pembrolizumab improves disease-free survival, according to a study published in the August 19 issue of New England Journal of Medicine. Toni K. Choueiri, MD, of the … Read More